AECL developed the CANDU reactor technology and AECL continues to own CANDU reactor technology. As part of the restructuring that commenced in 2009, AECL sold exclusive rights to the technology to SNC-Lavalin, which is now AtkinsRéalis.
The CANDU technology continues to be very important to AECL and the CNL. That's because the lab type of expertise around CANDU is very much in residence at our labs today. The engineering portion of CANDU was sold but not the research and development—not the fundamental technology portion. It's important to us to see CANDU continue to grow. We have that capability in our labs to continue to sustain CANDU technology.
I'm not sure if I answered your question directly.